Tirzepatide

Mounjaro is labeled for glycemic control in adults and children aged 10 years and older with type 2 diabetes, and to reduce major cardiovascular events in adults with type 2 diabetes at high risk. Zepbound is labeled for long-term weight management in eligible adults and for moderate to severe obstructive sleep apnea in adults with obesity. The sleep-apnea indication does not mean a patient should independently discontinue prescribed breathing support. ^{1, 2}

Labels warn about thyroid C-cell tumors and exclude people with personal or family medullary thyroid cancer or MEN2. Gastrointestinal effects, dehydration-related kidney problems, pancreatitis, gallbladder problems and severe allergy are relevant. Insulin or sulfonylureas can increase hypoglycemia risk. ^{1, 2}

Tirzepatide delays stomach emptying. Oral hormonal contraception requires a specific backup or non-oral contraception discussion when treatment starts or changes. Tell the prescribing and anesthesia teams about pregnancy plans and upcoming procedures. ²

FDA approval applies to the named Mounjaro and Zepbound products, not to a vial, tablet, troche or blend sold as compounded tirzepatide. A compounded preparation is not reviewed by FDA for safety, effectiveness or quality before marketing. If a clinician identifies an individual medical need for compounding, the conversation should name the ingredient, route, concentration, pharmacy and reason the approved product cannot meet that need. A seller's use of a familiar ingredient name does not verify what is in the container. ^{1, 2}

Ask how the clinical team will review digestive symptoms, fluid intake, blood glucose and other medicines while treatment changes. Insulin and sulfonylureas can add to low-glucose risk. Because tirzepatide can affect absorption of oral medicines, the prescriber needs a complete medication list rather than only diabetes or weight-management drugs. Confirm who to contact after a missed use, a prolonged illness, or a prescription change; do not improvise by doubling a dose or combining products. ^{1, 2}

Severe, persistent abdominal pain may signal pancreatitis and needs prompt assessment. Upper abdominal pain, fever, jaundice or pale stools may point to gallbladder disease. Repeated vomiting or diarrhea can cause dehydration and kidney problems. Seek emergency help for breathing difficulty, facial or throat swelling, fainting, or another severe allergic-reaction symptom. Tell urgent-care and anesthesia teams the exact product and when it was last used, because delayed stomach emptying may matter around procedures. ^{1, 2}

Keep the current carton or pen label, medication guide, prescriber's directions and pharmacy contact together. Record the product name, strength, last use and any side effects or missed uses. If the brand, device or pharmacy changes, compare the new directions before using it. A photo of the old label can help reconcile history, but only the current prescription and dispensed label direct current use. ^{1, 2}